Form 4 for SNPS Synopsys
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-17 · accession 0001199719-23-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-22 | 2023-02-17 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $134.41 | +3,464 | 26.7K | +15% | +$465.6K |
| DM | 2023-02-22 | 2023-02-17 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | S - Sale+OE | $353.91 | -3,464 | 25.1K | -12% | -$1.23M |
| DM | 2023-02-22 | 2022-12-13+ | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | G - Gift | $0.00 | -750 | 25.1K | -3% | $0 |
| DM | 2023-02-22 | 2023-02-17 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | A - Grant | $0.00 | +6,498 | 4,875 | New | $0 |
| DM | 2023-02-22 | 2023-02-17 | SNPS | RUNKEL JOHN F JR | GC, Corp. Sec | M - OptEx | $0.00 | -3,464 | 4,556 | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-17 | M | A | 569 | $234.17 | 25,681 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-17 | S | D | 1,323 | $353.91 | 25,112 | D | — | — | (F2) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $350.83 to $357.39. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 3 | Common | Common Stock | 2022-12-13 | G | D | 650 | $0.00 | 25,212 | D | — | — | (F1) Gift |
| 4 | Common | Common Stock | 2022-12-14 | G | D | 100 | $0.00 | 25,112 | D | — | — | (F1) Gift |
| 5 | Common | Common Stock | 2023-02-17 | M | A | 1,323 | $89.76 | 26,435 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-17 | S | D | 1,572 | $353.91 | 25,112 | D | — | — | (F2) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $350.83 to $357.39. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 7 | Common | Common Stock | 2023-02-17 | M | A | 1,572 | $135.88 | 26,684 | D | — | — | |
| 8 | Common | Common Stock | 2023-02-17 | S | D | 569 | $353.91 | 25,112 | D | — | — | (F2) Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $350.83 to $357.39. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range. |
| 9 | Derivative | Restricted Stock Units | 2023-02-17 | A | A | 1,623 | $0.00 | 1,623 | D | $0.00 · 2024-03-15 to 2027-03-15 | 1,623 Common Stock | (F7) 25% of the units vest on the date shown followed by three equal annual installments, subject to continued service through each vesting date. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-17 | A | A | 4,875 | $0.00 | 4,875 | D | $354.45 · 2024-02-17 to 2030-02-17 | 4,875 Common Stock | (F4) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-17 | M | D | 1,572 | $0.00 | 6,288 | D | $135.88 · 2020-12-12 to 2026-12-12 | 1,572 Common Stock | (F4) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-17 | M | D | 1,323 | $0.00 | 0 | D | $89.76 · 2019-12-12 to 2025-12-12 | 1,323 Common Stock | |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-02-17 | M | D | 569 | $0.00 | 4,556 | D | $234.17 · 2021-12-10 to 2027-12-10 | 569 Common Stock | (F4) 1/4 of the grant becomes exercisable on the date shown with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |